Photo of David Collingridge taken from LinkedIn
Mar 24, 2024, 08:36
David Collingridge: Delighted to be acting as co-lead of the Abstract Programme at this year’s World Cancer Congress
David Collingridge, Editor-in-Chief at The Lancet Oncology, shared a post by the Union of International Cancer Control (UICC) on LinkedIn:
“Delighted to be acting as co-lead of the Abstract Programme at this year’s World Cancer Congress. Time to submit your abstracts! See you in Geneva.”
Quoting the Union of International Cancer Control (UICC)’s post:
“Submit your abstract for the 2024 World Cancer Congress! The Congress will convene in Geneva from 17 – 19 September, and give the global cancer community the chance to discuss innovations, and exchange ideas on equity and sustainability in cancer care.”
Source: David Collingridge/LinkedIn and UICC/LinkedIn